SIL1 and amyotrophic lateral sclerosis: Accordingly, SIL1 deficiency enhances ALS pathology, whereas SIL1 overexpression affords significant neuroprotection related to improved ER proteostasis and reduced SOD1 aggregation (reviewed in Rozas et al., 2017).